Juvion-001 is built on robust ingredient-level evidence and clinical reasoning. We are honest about what is established, what is emerging, and what is not.
Juvion-001 is classified as a food supplement (nutraceutical) under Swiss law. It is not a medicinal product and does not make therapeutic claims. It is best positioned as adjunctive support — alongside exercise, balanced nutrition and medical care — not as treatment.
For healthcare professionalsIngredient-level evidence is robust. Clinicians should differentiate this from drug-level RCT evidence applied to a finished product.
First measurable shifts in cellular energy and fatigue resilience.
Measurable changes in stamina, coordination and responsiveness.
Strength reliability, mobility quality and movement confidence.
Variability increases with age above 75, multimorbidity and sedentary baseline. Best paired with resistance training, balance work, adequate protein and Vitamin D optimisation.
Used as directed in healthy adults and elderly populations, Juvion-001 is generally well tolerated. We disclose every known consideration so clinicians and users can make informed choices.
Possible mild GI discomfort (creatine), occasional headache (NADH, rare), mild hypotensive effect (L-arginine).
Chronic kidney disease · polypharmacy in frail elderly · cardiovascular instability · diabetes monitoring.
Advanced renal impairment · complex anticoagulation regimens · pregnancy and lactation.
Join the waitlist for first availability, founder-team updates and member-only briefings on the science of neuromuscular longevity.
No spam. Quarterly updates only.
